Ignite Creation Date:
2024-05-06 @ 7:38 PM
Last Modification Date:
2024-10-26 @ 3:11 PM
Study NCT ID:
NCT06087653
Status:
RECRUITING
Last Update Posted:
2023-10-18
First Post:
2023-09-20
Brief Title:
Safety Efficacy and Pharmacokinetics of Continuous Subcutaneous Lenalidomide in Multiple Myeloma MM
Sponsor:
Starton Therapeutics Inc
Organization:
Starton Therapeutics Inc
Organization Data
Organization:
Starton Therapeutics Inc
Class:
INDUSTRY
Study ID:
STAR LLD MM 023
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Starton Therapeutics Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None